1 💰 商业科技 Ars Technica 2026-08-07 💬 Moderna's mRNA flu shot earns FDA approval after rollercoaster review Moderna mRNA流感疫苗获批，老年人群迎来新选择，技术路线再获验证。 Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up. moderna mrna疫苗 流感疫苗 fda 生物技术